Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)
Clinical trial NCT06729606 · COMPLETED
Trial details
- NCT number
- NCT06729606
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-20
- Primary completion
- 2022-08-22
- Enrollment
- 471
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.